Roth Capital analyst Eric Handler raised the firm’s price target on Cinemark (CNK) to $35 from $34 and keeps a Buy rating on the shares after the company reported “strong outperformance” in a soft Q3 box office environment. Having paid off its pandemic related debt and reduced its net leverage, Cinemark has “significant financial flexibility” to reinvest in the business, return capital to shareholders, and explore M&A, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
